Targeting DNA repair pathways for cancer treatment: what's new?
about
Oxidant and environmental toxicant-induced effects compromise DNA ligation during base excision DNA repairDrugging the Cancers Addicted to DNA Repair.Revisiting the hallmarks of cancer.Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.A pilot study on the prevalence of DNA palindromes in breast cancer genomesDNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.Reprint of "Oxidant and environmental toxicant-induced effects compromise DNA ligation during base excision DNA repair".The interplay between DNA repair and autophagy in cancer therapyStructure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.Targeting DNA repair and replication stress in the treatment of ovarian cancer.Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cellsAptamers for DNA Damage and Repair.Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.An engineered cell line lacking OGG1 and MUTYH glycosylases implicates the accumulation of genomic 8-oxoguanine as the basis for paraquat mutagenicity.Cell Cycle Model System for Advancing Cancer Biomarker Research.Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland.CDYL1 fosters double-strand break-induced transcription silencing and promotes homology-directed repair.Potent and Selective Inhibitors of 8-Oxoguanine DNA Glycosylase (OGG1).Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation.Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells.STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.DNA Mutations May Not Be the Cause of Cancer.DNA repair pathways and cisplatin resistance: an intimate relationshipBlocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survivalMelanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugsMulti-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer CellsDevelopment of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
P2860
Q28088379-B4B1CCB7-F300-444B-810D-C46110B02420Q33702497-83CFC298-EFA0-4260-9DB5-1D4CBA7840FAQ33732986-46BC09E3-E944-4231-8AF7-05911D60C118Q36028930-14BC474C-EDAE-4944-A548-BAA541F50506Q36258533-4BE4F5F0-5901-4055-9011-71B26646F509Q36349712-79638109-C80D-417C-BAD4-BC55C16DF53FQ36395916-6F8B2E19-6D29-4869-B231-DDDA5989C63DQ38488109-681ABF00-16E0-4AF7-A178-0E92DBFC20BDQ38733657-1A22A07C-1A8D-4373-899B-D3212C489C08Q38734017-32BBA735-367D-47D0-BE01-7908C8E8321DQ38824661-900C7756-5810-4B93-9F50-D5F02F092623Q39393235-702D9B00-F4EA-433B-B4CF-1030F39E7DCFQ41144456-4AE24EB8-9061-4267-A898-E0E991CF666FQ41315657-CBCDD829-80C9-4E6D-9EB9-71B076DE9111Q44337974-6C9ACE31-6895-41CA-AE62-29CBA69637BCQ46063736-30509ED0-AFEC-43C4-9D84-1BC61C972BC8Q47142505-C08F3315-38C2-4A7F-8B59-FC630CD8395FQ47208435-254B78D0-88E5-4885-A45E-4A56BBD727B1Q47262784-38BECDD6-252F-42FD-B35F-BD30235E7757Q47360892-E3960732-84C4-4753-A6F9-E42AF00D0642Q47362873-1CDBA8BF-5AE4-434F-808A-F3E667A47561Q47803276-A31CA238-B356-42A2-B251-50CC85E01D9AQ48043803-8F02E5D3-DB21-41AD-AB29-F56BB0B404C6Q48298859-7B08D963-2CF6-4DC6-8D44-316D5ADEAD9AQ51825149-DF187970-67C9-4889-AFD8-D100C740B08AQ52665635-D3469539-938D-4F41-9038-2935BAF3A53CQ52684496-05E19297-767C-499E-B5EC-79C50AF935ECQ53725947-16C32951-CBBC-4AC1-BCF0-AE87142F83ACQ58699219-3FE1F944-6E24-4A46-80E6-8CFB986B906EQ58743974-4E7F6EBA-475B-4F23-9390-C93CC409219FQ58751951-6F742C8B-8928-4186-BBCE-1B830F90B487Q58792021-8416BA51-6D92-43E4-A283-0F0DD0258AA6Q58796916-5995AF35-40C7-4ADE-9DCA-451F614FFE45
P2860
Targeting DNA repair pathways for cancer treatment: what's new?
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting DNA repair pathways for cancer treatment: what's new?
@ast
Targeting DNA repair pathways for cancer treatment: what's new?
@en
Targeting DNA repair pathways for cancer treatment: what's new?
@nl
type
label
Targeting DNA repair pathways for cancer treatment: what's new?
@ast
Targeting DNA repair pathways for cancer treatment: what's new?
@en
Targeting DNA repair pathways for cancer treatment: what's new?
@nl
prefLabel
Targeting DNA repair pathways for cancer treatment: what's new?
@ast
Targeting DNA repair pathways for cancer treatment: what's new?
@en
Targeting DNA repair pathways for cancer treatment: what's new?
@nl
P2860
P356
P1433
P1476
Targeting DNA repair pathways for cancer treatment: what's new?
@en
P2093
Derek Logsdon
Mark R Kelley
P2860
P304
P356
10.2217/FON.14.60
P407
P577
2014-05-01T00:00:00Z